You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Iomab-B

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-ALL, DLBCL, B ALL Trial in New York (131-I Apamistamab, CAR T-cell)

Recruiting
  • B-ALL
  • +10 more
  • 131-I Apamistamab
  • CAR T-cell
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 7, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Iomab-B
  • +2 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +9 more
  • Allogeneic Bone Marrow Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 4, 2021

Pertussis/Whooping Cough Trial in Southampton (Bordetella pertussis B1917, Azithromycin Pill)

Recruiting
  • Pertussis/Whooping Cough
  • Bordetella pertussis B1917
  • Azithromycin Pill
  • Southampton, Hampshire, United Kingdom
    NIHR Clinical Research Facility
Apr 26, 2023

Fibronectin Type ? Domain Containing Protein 5 \ Irsin Gene

Recruiting
  • Hepatitis B, Chronic
  • genotyping
  • Sohag, Egypt
    Sohag university Hospital
Sep 4, 2023

T-bet B Cells in Persistent Virus Control After Discontinuance

Completed
  • Chronic HBV Infection
  • Drug Withdrawal
  • T-bet B cell
  • Shanghai, China
    Changhai hospital
Sep 1, 2023

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

COVID-19, Influenza Trial in United States (Lucira COVID-19 & Flu Test)

Completed
  • COVID-19
  • Influenza
  • Lucira COVID-19 & Flu Test
  • Cullman, Alabama
  • +6 more
Nov 16, 2023

Total Knee Replacement, Knee Arthroplasty Trial in New Haven (Bupivacaine-Liposomal Bupivacaine, Bupivacaine -Dexamethasone

Recruiting
  • Total Knee Replacement
  • Knee Arthroplasty
  • Bupivacaine-Liposomal Bupivacaine
  • Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate
  • New Haven, Connecticut
  • +1 more
Feb 17, 2023

Tenofovir Disoproxil Fumarate and Entcavir in Treatment of

Recruiting
  • Chronic Hepatitis b Patients
  • Tenofovir Disoproxil Fumarate and Entcavir
  • Sohag, Egypt
    Sohag University hospitals
May 22, 2023

Drug-Induced Nephropathy Trial in Cairo (N Acetylcysteine)

Recruiting
  • Drug-Induced Nephropathy
  • N Acetylcysteine
  • Cairo, Egypt
    Helwan University
Nov 7, 2023

B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

Recruiting
  • B-Cell Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2023

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Epithelial Lining Fluid and Blood Pharmacokinetics and

Recruiting
  • Polymyxin B
  • +3 more
  • nebulized polymyxin B
  • Nanjing, Jiangsu, China
    Zhongda Hospital Affiliated to Southeast University
Oct 7, 2023

JAK-i on RA B-lymphocytes Tolerance and Disease Resolution

Recruiting
  • Rheumatoid Arthritis
  • B lymphocyte profiling
  • Rome, Italy
    Division of Clinical Immunology, Fondazione Policlinico Universi
Feb 22, 2023

Non-hodgkin Lymphoma Trial (HY004)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • HY004
  • (no location specified)
Aug 21, 2023

Hypothermia's Effect on Hepatitis B Vaccination

Not yet recruiting
  • Hypoxic-Ischemic Encephalopathy
  • +2 more
  • Hypothermia Protocol
  • (no location specified)
Mar 15, 2023

SARS-CoV2 Infection, Covid19, SARS-CoV-2 Acute Respiratory Disease Trial in Worldwide (BNT162b2, BNT162b2 (B.1.1.7 + B.1.617.2),

Active, not recruiting
  • SARS-CoV2 Infection
  • +3 more
  • BNT162b2
  • +5 more
  • Long Beach, California
  • +34 more
Jan 10, 2023

NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

Recruiting
  • NHL
  • NHL, Relapsed, Adult
  • Birmingham, Alabama
  • +4 more
May 31, 2023

Healthy Participants Trial in Tempe (Aficamten, Aficamten-matching Placebo, Moxifloxacin)

Recruiting
  • Healthy Participants
  • Tempe, Arizona
    Celerion, Inc 2420
Jun 27, 2023

Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))

Recruiting
  • Hematologic Malignancy
  • B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
  • Duarte, California
    City of Hope
Oct 20, 2023

Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • CC312
  • Tianjin, Tianjin, China
    InstituteHBDH
Sep 12, 2023

Healthy Trial in Shenyang (HSK7653(5mg), HSK7653(25mg))

Completed
  • Healthy
  • Shenyang, Liaoning, China
    The First Affiliated Hospital of Liaoning University of Traditio
Aug 22, 2023

Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)

Recruiting
  • Hemophilia B
  • Sodium valproate extended-release tablets
  • Beijing, China
    PLA General Hospital
Jun 17, 2023

Breast Cancer Trial (Giredestrant, Giredestrant plus triptorelin, Anastrozole plus triptorelin)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 13, 2023